EZH2 and prostate cancer: Moreover, we determined whether DNACR regulated cell invasion synergistically with EZH2 and whether DANCR affected the effect of androgen-AR signaling and enzalutamide, an inhibitor of AR, on migration and invasion of prostate cancer cells.